Takeda Pharmaceutical are launching an open innovation initiative, inviting researchers to submit their ideas and technologies across five different focus areas, up to £60k / €70k / $100k (AUD). Summarised below are the interests of Takeda relating to DMPK and safety research for Therapeutics and Drug Delivery Systems. In the attached application form, each of these topics have been expanded upon to give further detail of proposals.
Submissions should be relevant to one or more of the following titles:
- REF #24 Microphysiological blood-brain barrier (BBB...